AACR Award Targets Younger Ca Researchers

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 4 No 10
Volume 4
Issue 10

PHILADELPHIA-The American Association for Cancer Research (AACR) is sponsoring its fourth annual Gertrude Elion Cancer Research Award. This award, provided through an educational grant from Glaxo Wellcome Oncology, is open to nontenured cancer investigators in clinical, basic, or translational research in the United States and Canada.

PHILADELPHIA-The American Association for Cancer Research (AACR)is sponsoring its fourth annual Gertrude Elion Cancer ResearchAward. This award, provided through an educational grant fromGlaxo Wellcome Oncology, is open to nontenured cancer investigatorsin clinical, basic, or translational research in the United Statesand Canada.

The application deadline is February 15, 1996, and the award willbe presented at the AACR annual meeting in Washington, DC, inApril, 1996.

The award recipient must have completed postdoctoral studies orclinical fellowships no later than July 1, 1996, and ordinarilynot more than 5 years prior to the award year. The 1-year awardincludes a $30,000 grant plus travel to the AACR annual meeting.

For more information, contact Jenny Anne Horst-Martz at the AACRin Philadelphia. Phone: 215-440-9300; Email: aacr@aol.com.

Recent Videos
Once a patient-specific dose is determined, an all-oral combination of revumenib plus decitabine/cedazuridine and venetoclax may be “very good” in AML.
Patients with lung cancer who achieve a complete response with neoadjuvant therapy may not experience additional benefit with adjuvant immunotherapy.
Numerous trials have displayed the evolution of EGFR inhibition alone or with chemotherapy/radiation in the EGFR-mutated lung cancer space.
2 experts are featured in this series.
Although high grade adverse effects are infrequent among patients undergoing treatment for SCLC, CRS and ICANS may occur in higher frequencies.
Two experts are featured in this series.
Co-hosts Kristie L. Kahl and Andrew Svonavec highlight what to look forward to at the 67th Annual ASH Meeting in Orlando.
4 experts are featured in this series.
Related Content